Journal
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
Volume 5, Issue 2, Pages 83-87Publisher
WILEY
DOI: 10.1007/s13539-014-0149-7
Keywords
-
Ask authors/readers for more resources
The two most common muscle wasting diseases in adults are sarcopenia and cachexia. Despite differences in their pathophysiology, it is believed that both conditions are likely to respond to drugs that increase muscle mass and muscle strength. The current gold standard in this regard is exercise training. This article provides an overview of candidate drugs to treat muscle wasting disease that are available or in development. Drugs highlighted here include ghrelin agonists, selective androgen receptor molecules, megestrol acetate, activin receptor antagonists, espindolol, and fast skeletal muscle troponin inhibitors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available